References
- Feng J, Li Q. How to ensure vaccine safety: an evaluation of China's vaccine regulation system. Vaccine 2021;39:5285-94. https://doi.org/10.1016/j.vaccine.2021.07.081
- Canoui E, Launay O. History and principles of vaccination. Rev Mal Respir 2019;36:74-81. https://doi.org/10.1016/j.rmr.2018.02.015
- Iwasaki A, Omer SB. Why and how vaccines work. Cell 2020;183:290-5. https://doi.org/10.1016/j.cell.2020.09.040
- Shukla VV, Shah RC. Vaccinations in primary care. Indian J Pediatr 2018;85:1118-27. https://doi.org/10.1007/s12098-017-2555-2
- Rappuoli R, Pizza M, Del Giudice G, De Gregorio E. Vaccines, new opportunities for a new society. Proc Natl Acad Sci U S A 2014;111:12288-93. https://doi.org/10.1073/pnas.1402981111
- Saleh A, Qamar S, Tekin A, Singh R, Kashyap R. Vaccine development throughout history. Cureus 2021;13:e16635.
- Zakir F, Islam F, Jabeen A, Sivagurunathan Moni S. Vaccine development: a historical perspective. Biomed Res 2019;30:452-5. https://doi.org/10.35841/biomedicalresearch.30-19-203
- Das S, Kar SS, Samanta S, Banerjee J, Giri B, Dash SK. Immunogenic and reactogenic efficacy of Covaxin and Covishield: a comparative review. Immunol Res 2022;70:289-315. https://doi.org/10.1007/s12026-022-09265-0
- Broom D. From cholera to COVID: a brief history of vaccines. World Economic Forum 2022 Apr 27 [cited 2022 Sep 20]. Available from: https://www.weforum.org/agenda/2022/04/from-cholera-to-covid-a-brief-history-of-vaccines/
- Jadhav VR, Aher JS, Bhagare AM, Dhaygude AC. COVID-19 era: what's impact of the lockdown on India's environment? J Chem Environ Sci Its Appl 2020;7:1-6. https://doi.org/10.15415/jce.2020.71001
- Batra S, Sharma S, Verma P, Arora N. COVID-19: an Insight on the third respiratory global emergency of the century. Coronaviruses 2021;2:339-45. https://doi.org/10.2174/2666796701999200915144814
- Kciuk M, Mujwar S, Rani I, et al. Computational bioprospecting guggulsterone against ADP ribose phosphatase of SARS-CoV-2. Molecules 2022;27:8287.
- Rodrigues CM, Plotkin SA. Impact of vaccines; health, economic and social perspectives. Front Microbiol 2020;11:1526.
- Han X, Xu P, Ye Q. Analysis of COVID-19 vaccines: types, thoughts, and application. J Clin Lab Anal 2021;35:e23937.
- COVID19 Vaccine Tracker [Internet]. [place unknown]: VIPER Group COVID19 Vaccine Tracker Team; 2022 [cited 2022 Sep 20]. Available from: https://covid19.trackvaccines.org/
- Sharma M, Mordani S. Covaxin, Covishield granted market approval in India but conditions apply. India Today [Internet]. 2022 Jan 27 [cited 2022 Sep 20]. Available from: https://www.indiatoday.in/coronavirus-outbreak/vaccine-updates/story/covaxin-covishield-granted-regularmarket-approval-india-1905218-2022-01-27
- Kumar A, Shrivastava S, Tiwari P. Management of adverse events post-COVID-19 vaccination with Covaxin and Covishield: a literature review. One Health Bull 2022;2:6.
- ChAd36-SARS-CoV-S COVID-19 vaccine (recombinant): summary of product characteristics (SmPC) [Internet]. Shamirpet: Bharat Biotech International Ltd.; 2022 [cited 202 Sep 20]. Available from: https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=OTAwOQ==
- Bharat Biotech. Restricted use in emergency situation of COVID-19 SARS-CoV-2 vaccine [Internet]. Hyderabad: Bharat Biotech; 2019 [cited 2022 Nov 24]. Available from: http://www.bharatbiotech.com
- Sharun K, Dhama K. India's role in COVID-19 vaccine diplomacy. J Travel Med 2021;28:taab064.
- Module 1: administrative/legal information: trivalent seasonal influenza virus-like particle (VLP) vaccine: summary of product characteristics [Internet]. Ahmedabad: CADILA Pharmaceuticals Limited; 2018 [cited 2022 Nov 24]. Available from: https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=NDE3NA==
- Summary of product characteristics [Internet]. Ghatkesar: Dano Vaccines and Biologicals Private Limited; 2010 [cited 2022 Nov 24]. Available from: https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=NDE3Ng==
- Kakar A, Gogia A, Solanki SK, Jadiya A, Singh D. Safety and immunogenicity of SURE RAB(TM), an inactivated cell culture derived rabies vaccine: a comparative, phase III clinical trial. Indian J Med Microbiol 2021;39:63-6. https://doi.org/10.1016/j.ijmmb.2021.01.001
- Arora A, Nagpal M, Aggarwal G. Microneedle mediated vaccine delivery: a comprehensive review. J Pharm Technol Res Manag 2017;5:163-84. https://doi.org/10.15415/jptrm.2017.52011
- Okuyan O, Elgormus Y, Sayili U, Dumur S, Isik OE, Uzun H. The effect of virus-specific vaccination on laboratory infection markers of children with acute rotavirus-associated acute gastroenteritis. Vaccines (Basel) 2023;11:580.
- Priyanka, Chopra H, Choudhary OP. mRNA vaccines as an armor to combat the infectious diseases. Travel Med Infect Dis 2023;52:102550.
- Ella R, Babji S, Ciarlet M, Blackwelder WC, Vadrevu KM. A randomized, open-labelled, non-inferiority phase 4 clinical trial to evaluate the immunogenicity and safety of the live, attenuated, oral rotavirus vaccine, ROTAVAC(R) in comparison with a licensed rotavirus vaccine in healthy infants. Vaccine 2019;37:4407-13. https://doi.org/10.1016/j.vaccine.2019.05.069
- Lahariya C. A brief history of vaccines & vaccination in India. Indian J Med Res 2014;139:491-511.
- Bhattacharya S. Expunging variola: the control and eradication of smallpox in India, 1947-1977. Hyderabad: Orient Blackswan; 2006.
- Madhavi Y. Vaccine policy in India. PLoS Med 2005;2:e127.
- History [Internet]. Hyderabad: Biological E. Limited; c2020 [cited 2022 Nov 24]. Available from: https://www.biologicale.com/history.html
- Chakraborty C, Agoramoorthy G. India's cost-effective COVID-19 vaccine development initiatives. Vaccine 2020;38:7883-4. https://doi.org/10.1016/j.vaccine.2020.10.056
- Doherty M, Buchy P, Standaert B, Giaquinto C, PradoCohrs D. Vaccine impact: benefits for human health. Vaccine 2016;34:6707-14. https://doi.org/10.1016/j.vaccine.2016.10.025
- World Data Bank. World development indicators [Internet]. Washington (DC): The World Bank; 2017 [cited 2022 Sep 20]. Available from: https://datatopics.worldbank.org/world-development-indicators/
- Hooda SK. Out-of-pocket payments for healthcare in India: who have affected the most and why? J Health Manag 2017;19:1-15. https://doi.org/10.1177/0972063416682535
- Wagstaff A, Flores G, Smitz MF, Hsu J, Chepynoga K, Eozenou P. Progress on impoverishing health spending in 122 countries: a retrospective observational study. Lancet Glob Health 2018;6:e180-92. https://doi.org/10.1016/S2214-109X(17)30486-2
- Nandi A, Shet A. Why vaccines matter: understanding the broader health, economic, and child development benefits of routine vaccination. Hum Vaccin Immunother 2020;16:1900-4. https://doi.org/10.1080/21645515.2019.1708669
- Chatterjee A, Chakravarty A. Neurological complications following COVID-19 vaccination. Curr Neurol Neurosci Rep 2023;23:1-14. https://doi.org/10.1007/s11910-022-01247-x
- Benefits and risks of vaccines [Internet]. Columbia (SC): South Carolina Department of Health and Environmental Control; 2022 [cited 2022 Sep 20]. Available from: https://scdhec.gov/benefits-risks-vaccines
- Koller CN, Schwerzmann CJ, Lang AS, Alexiou E, Krishnakumar J. Addressing different needs: the challenges faced by India as the largest vaccine manufacturer while conducting the world's biggest COVID-19 vaccination campaign. Epidemiologia (Basel) 2021;2:454-70. https://doi.org/10.3390/epidemiologia2030032
- Asundi A, O'Leary C, Bhadelia N. Global COVID-19 vaccine inequity: the scope, the impact, and the challenges. Cell Host Microbe 2021;29:1036-9. https://doi.org/10.1016/j.chom.2021.06.007
- Wouters OJ, Shadlen KC, Salcher-Konrad M, et al. Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment. Lancet 2021;397:1023-34. https://doi.org/10.1016/S0140-6736(21)00306-8
- Milstien JB, Batson A, Wertheimer AI. Vaccines and drugs: characteristics of their use to meet public health goals [Internet]. Washington (DC): World Bank; 2005 [cited 2022 Sep 20]. Available from: https://www.researchgate.net/publication/228615171_Vaccines_and_Drugs_Characteristics_of_Their_Use_to_Meet_Public_Health_Goals
- Wynaden D, Landsborough I, McGowan S, Baigmohamad Z, Finn M, Pennebaker D. Best practice guidelines for the administration of intramuscular injections in the mental health setting. Int J Ment Health Nurs 2006;15:195-200. https://doi.org/10.1111/j.1447-0349.2006.00423.x
- Rodger MA, King L. Drawing up and administering intramuscular injections: a review of the literature. J Adv Nurs 2000;31:574-82. https://doi.org/10.1046/j.1365-2648.2000.01312.x
- Kilic E, Kalay R, Kilic C. Comparing applications of intramuscular injections to dorsogluteal or ventrogluteal regions. J Exp Integr Med 2014;4:171-4. https://doi.org/10.5455/jeim.220514.rw.009
- Biswas S. Covid-19 nasal vaccine: are these the better solution?: all you need to know. Mint [Internet]. 2022 May 28 [cited 2022 Oct 5]. Available from: https://www.livemint.com/science/health/covid19-nasal-vaccine-are-these-the-better-solution-all-you-need-to-know-11653731602540.html
- Administer the vaccine(s) [Internet]. Atlanta (GA): Centers for Disease Control and Prevention; 2021 [cited 2022 Oct 5]. Available from: https://www.cdc.gov/vaccines/hcp/admin/administer-vaccines.html
- Clark EM, Pippin MM. Safe and effective administration of vaccines and epinephrine autoinjection. Treasure Island (FL): StatPearls Publishing; 2023.
- Vela Ramirez JE, Sharpe LA, Peppas NA. Current state and challenges in developing oral vaccines. Adv Drug Deliv Rev 2017;114:116-31. https://doi.org/10.1016/j.addr.2017.04.008
- Renukuntla J, Vadlapudi AD, Patel A, Boddu SH, Mitra AK. Approaches for enhancing oral bioavailability of peptides and proteins. Int J Pharm 2013;447:75-93. https://doi.org/10.1016/j.ijpharm.2013.02.030
- Jabbal-Gill I. Nasal vaccine innovation. J Drug Target 2010;18:771-86. https://doi.org/10.3109/1061186X.2010.523790
- Birkhoff M, Leitz M, Marx D. Advantages of intranasal vaccination and considerations on device selection. Indian J Pharm Sci 2009;71:729-31.
- Waltz E. How nasal-spray vaccines could change the pandemic. Nature 2022;609:240-2. https://doi.org/10.1038/d41586-022-02824-3
- Tiboni M, Casettari L, Illum L. Nasal vaccination against SARS-CoV-2: synergistic or alternative to intramuscular vaccines? Int J Pharm 2021;603:120686.
- CanSinoBIO. CanSinoBIO's Convidecia air receives approval in China [Internet]. Tianjin: CanSinoBIO; 2022 [cited 2022 Oct 5]. Available from: https://www.cansinotech.com/html/1/179/180/1100.html
- Bharat Biotech. Bharat Biotech's iNCOVACC world's first intra nasal vaccine receives approval for emergency use in India [Internet]. Hyderabad: Bharat Biotech; 2022 [cited 2022 Oct 5]. Available from: https://www.bharatbiotech.com/images/press/Bharat-Biotech-iNCOVACC-Worlds-First-Intra-Nasal-Vaccine-Receives-Approval.pdf
- Choudhary OP, Priyanka, Mohammed TA, Singh I. Intranasal COVID-19 vaccines: is it a boon or bane? Int J Surg 2021;94:106119.
- Latpate S, Salunkhe K, Pagar P. Regulatory aspects for vaccines in India and us an overview. Int J Res Eng Sci 2022;10:238-41.
- Tahamtan A, Charostad J, Hoseini Shokouh SJ, Barati M. An overview of history, evolution, and manufacturing of various generations of vaccines. J Arch Mil Med 2017;5:e12315.
- Annual report 2016-17: organization and infrastructure [Internet]. New Delhi: Ministry of Health and Family Welfare; 2018 [cited 2022 Oct 5]. Available from: https://main.mohfw.gov.in/sites/default/files/1201617.pdf
- Howard N, Walls H, Bell S, Mounier-Jack S. The role of National Immunisation Technical Advisory Groups (NITAGs) in strengthening national vaccine decision-making: a comparative case study of Armenia, Ghana, Indonesia, Nigeria, Senegal and Uganda. Vaccine 2018;36:5536-43. https://doi.org/10.1016/j.vaccine.2018.07.063
- Sathiaraj E. Better nutrition for a better future [Internet]. Geneva: James Lind Institute; 2021 [cited 2022 Oct 5]. Available from: https://www.jli.edu.in/blog/roles-and-responsibilities-ofcdsco/#:~:text=The%20central%20authorities%20are%20responsible,of%20bringing%20about20the%20uniformity
- Announcement: Indian Council of Medical Research: reference list [Internet]. New Delhi: Indian Council of Medical Research; 2017 [cited 2022 Oct 5]. Available from: http://www.icmr.nic.in/
- National regulatory agencies [Internet]. New Delhi: World Health Organization South-East Asia Region; [date unknown] [cited 2022 Oct 5]. Available from: https://www.who.int/southeastasia/activities/national-regulatory-agencies#:~:text=NRAs%20are%20national%20regulatory%20agencies,quality%20and%20safety%20and%20efficacy
- Regulation of vaccines: building on existing drug regulatory authorities [Internet]. Geneva: World Health Organization, Department of Vaccines and Other Biologicals; 1999 [cited 2022 Oct 5]. Available from: https://apps.who.int/iris/bitstream/handle/10665/65968/WHO_V-B_99.10_eng.pdf;jsessionid=6AB4805A2DA3FA6411F5E9C9DF49797A?sequence=1
- Goetz KB, Pfleiderer M, Schneider CK. First-in-human clinical trials with vaccines: what regulators want. Nat Biotechnol 2010;28:910-6. https://doi.org/10.1038/nbt0910-910
- Kondal A, Krishna GV, Bansal D. Clinical trial regulations in India: progress and challenges arising from recent amendments to schedule Y of the Drugs and Cosmetics (D&C) Act 1940 (D&C Rules 1945). Pharm Med 2016;30:1-13. https://doi.org/10.1007/s40290-015-0127-1
- Ethics committee [Internet]. New Delhi: Central Drugs Standard Control Organization; 2022 [cited 2022 Oct 31]. Available from: https://cdsco.gov.in/opencms/opencms/en/Clinical-Trial/Ethics-Committee/
- How are vaccines developed?: what are the stages? [Internet]. Mumbai: HDFC ERGO; 2022 [cited 2022 Sep 25]. Available from: https://www.hdfcergo.com/blogs/health-insurance/how-are-vaccines-developed-what-are-the-stages
- Thanuja MB, Maddi R. Comparison of regulatory approval process for vaccines development and manufacturing in India & USA. UPI J Pharm Med Health Sci 2021;4:18-24.
- Central Drug Standard Control Organization (CDSCO) user manual for e-governance solution for CDSCO: version 1.0 [Internet]. Pune: Centre for Development of Advanced Computing; 2017 [cited 2022 Oct 25]. Available from: https://cdsco.gov.in/opencms/export/sites/CDSCO_WEB/Pdf-documents/SUGAM_user_manual.pdf
- Kumar D, Rahi S, Rana A. Comparative study of updated clinical trial regulations in India with respect to Australia, Europe, Japan and US. Int J Drug Regul Aff 2021;9:48-61. https://doi.org/10.22270/ijdra.v9i1.455
- Walter EB, Moody MA. Vaccine development: steps to approval of an investigational vaccine. N C Med J 2021;82:141-4.
- World Health Organization. Research ethics committees: basic concepts for capacity-building. Geneva: World Health Organization; 2009.
- Kadam R, Karandikar S. Ethics committees in India: facing the challenges! Perspect Clin Res 2012;3:50-6. https://doi.org/10.4103/2229-3485.96444
- New Drugs and Clinical Trial Rules, 2019: NDCTR_G.S.R. 227(E) [Internet]. New Delhi: Central Drugs Standard Control Organization; 2019 [cited 2022 Oct 25]. Available from: https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=OTI4MA==
- Dellepiane N, Pagliusi S; Registration Experts Working Group. Challenges for the registration of vaccines in emerging countries: differences in dossier requirements, application and evaluation processes. Vaccine 2018;36:3389-96. https://doi.org/10.1016/j.vaccine.2018.03.049
- Knipe DM, Levy O, Fitzgerald KA, Muhlberger E. Ensuring vaccine safety. Science 2020;370:1274-5. https://doi.org/10.1126/science.abf0357
- Gustafson CE, Kim C, Weyand CM, Goronzy JJ. Influence of immune aging on vaccine responses. J Allergy Clin Immunol 2020;145:1309-21. https://doi.org/10.1016/j.jaci.2020.03.017
- Salerno-Goncalves R, Sztein MB. Cell-mediated immunity and the challenges for vaccine development. Trends Microbiol 2006;14:536-42. https://doi.org/10.1016/j.tim.2006.10.004
- Zimmermann P, Curtis N. Factors that influence the immune response to vaccination. Clin Microbiol Rev 2019;32:e00084-18.
- World Health Organization. Ten threats to global health in 2019 [Internet]. Geneva: World Health Organization; 2019 [cited 2022 Oct 20]. Available from: https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019
- Neumann-Bohme S, Varghese NE, Sabat I, et al. Once we have it, will we use it?: a European survey on willingness to be vaccinated against COVID-19. Eur J Health Econ 2020;21:977-82. https://doi.org/10.1007/s10198-020-01208-6
- Lazarus JV, Ratzan SC, Palayew A, et al. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med 2021;27:225-8. https://doi.org/10.1038/s41591-020-1124-9